Skip to content

Contrast indiced nephropaty (CIN) in patients undergoing primary angioplasty for acute myocardial infarction. Randomized trial on the effects of hydration with saline or sodium bicarbonate. - ND

Contrast indiced nephropaty (CIN) in patients undergoing primary angioplasty for acute myocardial infarction. Randomized trial on the effects of hydration with saline or sodium bicarbonate. - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-002149-20-IT
Enrollment
Unknown
Registered
2007-06-15
Start date
2007-04-18
Completion date
Unknown
Last updated
2012-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AMI MedDRA version: 6.1 Level: SOC Classification code 10007541

Interventions

Pharmaceutical Form: Solution for injection INN or Proposed INN: Electrolytes Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 7140-

Sponsors

AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - age >18 years - tipycal chest pain lasting 30 min. associated with ST elevation of 0.2 mV in at least 2 leads or LBB - informed consent available Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - substitutive renal treatment - coronary anatomy not suitable for angioplasty - need for emergency coronary by pass

Design outcomes

Primary

MeasureTime frame
Main Objective: To evaluate the lower risk of CIN in patients with AMI undergoing primary PCI after hydration with NA bicarbonate or NA CL;Secondary Objective: In hospital MACE (death, acute renal insufficiency, major bleeding, re-AMI);Primary end point(s): CIN incidence evaluated by an increase of 25% of basal creatinine or 0,5 mg/dl as absolute value.

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026